About: Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.25 (-3.85%)
DXBASXDimerix Ltd
Carregando status da lista de acompanhamento…
Dimerix Ltd share price
DXB price activity
Último preço
$ 0,250
Variação (24h)
-0,01 AUD (-3,85%)
Volume
1.35M
Volume (média 4 sem.)
-
Abertura
$ 0,27
Variação do dia
$ 0,25 - $ 0,27
Fechamento anterior
$ 0,26
Último negócio
10 Sep, 6:10 am GMT+0
Atrasado
10 Sep, 6:10 am GMT+0
DXB price performance
-13,79%
5D
-9,09%
1M
-54,55%
YTD
-48,98%
1Y
Atrasado
10 Sep, 6:10 am GMT+0
quote.marketSignals